Add-on Acquisition • Life Science

CellCarta Acquires Primity Bio

On August 21, 2018, CellCarta acquired life science company Primity Bio

Acquisition Context
  • This is CellCarta’s 2nd transaction in the Life Science sector.
  • This is CellCarta’s 1st transaction in the United States.
  • This is CellCarta’s 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date August 21, 2018
Target Primity Bio
Sector Life Science
Buyer(s) CellCarta
Deal Type Add-on Acquisition

Target Company

Primity Bio

Fremont, California, United States
Primity Bio, Inc. is a provider of cutting-edge flow cytometry services with deep expertise in assay development, early drug discovery, pre-clinical animal sample analysis, biomarker discovery, and advanced human clinical sample analysis. Primity's clinical unit delivers fully customized and complex immunophenotyping, receptor occupancy, and cell signaling assays of clinical samples for exploratory pharmacodynamic analysis. Primity also offers analysis of pre-clinical and clinical samples by CyTOF (mass cytometry) which expands the number of measurable biomarkers per sample to over 35.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

CellCarta

Montreal, Quebec, Canada

Category Company
Founded 2000
Sector Life Science
Employees700
DESCRIPTION

CellCarta is a provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. CellCarta was founded in 2000 and is based in Montreal, Quebec.


Deal Context for Buyer #
Overall 2 of 7
Sector: Life Science 2 of 7
Type: Add-on Acquisition 1 of 6
State: California 1 of 3
Country: United States 1 of 3
Year: 2018 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-09 ImmuneHealth - Monitoring Laboratory

Gosselies, Belgium

ImmuneHealth - Monitoring Laboratory is a provider of fully operational immune monitoring laboratory infrastructure with well-established expertise, quality processes and industry services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-30 Serametrix

Carlsbad, California, United States

Serametrix Corp. provides immune monitoring solutions for better understanding of monitoring immune responses to immunotherapies in clinical trial cancer patients. Serametrix offers flow cytometry services in CLIA-certified laboratories to support clinical and preclinical trials. Serametrix Corp. was founded in 2008 and is based in Carlsbad, California.

Buy -